These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7591231)

  • 1. Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients.
    Csoka K; Nygren P; Graf W; Påhlman L; Glimelius B; Larsson R
    Int J Cancer; 1995 Nov; 63(3):356-60. PubMed ID: 7591231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients.
    Dhar S; Gullbo J; Csoka K; Eriksson E; Nilsson K; Nickel P; Larsson R; Nygren P
    Eur J Cancer; 2000 Apr; 36(6):803-9. PubMed ID: 10762755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients.
    Nygren P; Fridborg H; Csoka K; Sundström C; de la Torre M; Kristensen J; Bergh J; Hagberg H; Glimelius B; Rastad J
    Int J Cancer; 1994 Mar; 56(5):715-20. PubMed ID: 8314348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
    Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
    J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of CHS 828 in primary cultures of human hematological and solid tumors in vitro.
    Aleskog A; Bashir-Hassan S; Hovstadius P; Kristensen J; Höglund M; Tholander B; Binderup L; Larsson R; Jonsson E
    Anticancer Drugs; 2001 Nov; 12(10):821-7. PubMed ID: 11707649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic activity of calcein acetoxymethyl ester (Calcein/AM) on primary cultures of human haematological and solid tumours.
    Jonsson B; Liminga G; Csoka K; Fridborg H; Dhar S; Nygren P; Larsson R
    Eur J Cancer; 1996 May; 32A(5):883-7. PubMed ID: 9081371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia.
    Nygren P; Kristensen J; Jonsson B; Sundström C; Lönnerholm G; Kreuger A; Larsson R
    Leukemia; 1992 Nov; 6(11):1121-8. PubMed ID: 1434793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of standard and investigational cytotoxic drugs in primary cultures of tumor cells from patients with kidney and urinary bladder carcinomas.
    Nygren P; Csòka K; Larsson R; Busch C; Wester K; Malmström PU
    J Urol; 1999 Dec; 162(6):2200-4. PubMed ID: 10569619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R; Kristensen J; Sandberg C; Nygren P
    Int J Cancer; 1992 Jan; 50(2):177-85. PubMed ID: 1730510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours.
    Larsson R; Fridborg H; Liliemark J; Csoka K; Kristensen J; de la Torre M; Nygren P
    Eur J Cancer; 1994; 30A(7):1022-6. PubMed ID: 7946567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
    Csóka K; Tholander B; Gerdin E; de la Torre M; Larsson R; Nygren P
    Int J Cancer; 1997 Sep; 72(6):1008-12. PubMed ID: 9378534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
    Fridborg H; Jonsson B; Nygren P; Csoka K; Nilsson K; Oberg G; Kristensen J; Bergh J; Tholander B; Olsen L
    Br J Cancer; 1994 Jul; 70(1):11-7. PubMed ID: 8018519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity of topoisomerase II inhibitors in primary cultures of tumor cells from patients with human hematologic and solid tumors.
    Larsson R; Nygren P
    Cancer; 1994 Nov; 74(10):2857-62. PubMed ID: 7954248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. This month in Investigative Urology. A commentary on suramin demonstrates in vitro toxicity against transitional cell carcinoma cell lines and exposure to alkyllysophospholipids inhibits in vitro invasion of transitional cell carcinoma.
    Droller MJ
    J Urol; 1994 Nov; 152(5 Pt 1):1356-7. PubMed ID: 7933161
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
    Csoka K; Larsson R; Tholander B; Gerdin E; de la Torre M; Nygren P
    Gynecol Oncol; 1994 Aug; 54(2):163-70. PubMed ID: 7520407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic.
    Fridborg H; Jonsson E; Nygren P; Larsson R
    Eur J Cancer; 1999 Mar; 35(3):424-32. PubMed ID: 10448294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model.
    Ramirez LH; Juliéron M; Bonnay M; Koscielny S; Zhao Z; Gouyette A; Munck JN
    Invest New Drugs; 1995; 13(1):51-3. PubMed ID: 7499108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo.
    Morris AD; Léonce S; Guilbaud N; Tucker GC; Pérez V; Jan M; Cordi AA; Pierré A; Atassi G
    Anticancer Drugs; 1997 Sep; 8(8):746-55. PubMed ID: 9396618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay.
    Nygren P; Hagberg H; Glimelius B; Sundström C; Kristensen J; Christiansen I; Larsson R
    Ann Oncol; 1994; 5 Suppl 1():127-31. PubMed ID: 8172809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.